| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 34.44B | 32.16B | 35.09B | 37.33B | 36.22B |
| Gross Profit | 3.29B | 3.14B | 3.34B | 3.47B | 3.18B |
| EBITDA | 809.63M | 551.46M | 886.70M | 1.07B | 841.78M |
| Net Income | 428.80M | 237.45M | 556.19M | 657.62M | 516.73M |
Balance Sheet | |||||
| Total Assets | 18.42B | 17.24B | 18.92B | 17.52B | 16.13B |
| Cash, Cash Equivalents and Short-Term Investments | 924.60M | 763.00M | 2.25B | 1.41B | 799.00M |
| Total Debt | 813.75M | 783.39M | 576.30M | 597.49M | 714.65M |
| Total Liabilities | 10.40B | 9.73B | 11.65B | 10.84B | 9.85B |
| Stockholders Equity | 7.93B | 7.42B | 7.18B | 6.61B | 6.23B |
Cash Flow | |||||
| Free Cash Flow | 134.36M | -1.22B | 919.08M | 814.79M | 284.36M |
| Operating Cash Flow | 154.37M | -1.04B | 1.27B | 886.12M | 322.34M |
| Investing Cash Flow | 14.59M | -107.84M | -335.38M | -92.01M | -171.79M |
| Financing Cash Flow | -2.95M | -209.98M | -95.52M | -185.64M | -221.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥4.64B | 13.73 | ― | 2.27% | 1.79% | 31.63% | |
75 Outperform | ¥3.88B | 17.69 | ― | 2.98% | 7.64% | 37.45% | |
71 Outperform | ¥3.23B | 17.49 | ― | 3.15% | 1.14% | 50.47% | |
65 Neutral | ¥4.38B | 8.09 | ― | 3.29% | 7.11% | 80.59% | |
64 Neutral | ¥3.62B | 84.76 | ― | 1.28% | -1.01% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | ¥3.34B | -8.50 | ― | ― | -3.45% | 56.08% |
Tohoku Chemical Co., Ltd. reported first-quarter consolidated results for the period ended December 2025 showing largely flat revenue but sharply improved profitability. Net sales edged down 0.8% year-on-year to ¥8,885 million, but operating profit more than doubled to ¥241 million, ordinary profit rose 92.2% to ¥267 million, and profit attributable to owners of parent jumped 116.5% to ¥196 million, lifting basic earnings per share to ¥217.61. Comprehensive income also surged 218.1% to ¥285 million. On the balance sheet, total assets increased to ¥20,515 million and net assets to ¥8,173 million, though the capital adequacy ratio slipped from 43.0% to 39.4%, indicating expansion accompanied by some dilution of capital strength. Overall, the results suggest improved cost efficiency or margin enhancement despite slightly lower sales, supporting a stronger earnings profile at the start of the fiscal year, while the modest decline in the capital ratio will be monitored by investors as the company continues to grow its asset base.
The most recent analyst rating on (JP:7446) stock is a Buy with a Yen4313.00 price target. To see the full list of analyst forecasts on Tohoku Chemical Co., Ltd. stock, see the JP:7446 Stock Forecast page.